Status:
COMPLETED
Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer
Lead Sponsor:
Helwan University
Conditions:
Cancer, Bladder
Eligibility:
All Genders
Brief Summary
Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sens...
Eligibility Criteria
Inclusion
- All patients diagnosed with NMIBC or MIBC during diagnostic cystoscopy or by any radiologic investigation in the Urology department of Helwan university hospitals without being restricted to age or sex.
- All histological types of bladder cancer
- Newly diagnosed, recurrent cases, or even patients undergoing follow-up cystoscopy.
Exclusion
- Patients with elevated renal function according to their age as this will be a contraindication to DCE MRI.
- Patients with absolute contraindication to MRI (e.g.: metallic prosthesis).
- Patients with contraindication to undergo TURBT (e.g.: unfit for surgery).
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05324033
Start Date
May 1 2022
End Date
April 1 2023
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine, Helwan university
Badr, Cairo Governorate, Egypt, 11829